June 24, 2014
Limiting health care provider networks may save money for insurers grappling with the Affordable Care Act.
June 17, 2014
Tracking and analyzing patients’ adverse reactions to medications – a process known as pharmacovigilance – is crucial to patient safety.
June 13, 2014
How do we go about ”Ensuring Patient Access to Cancer Drugs”? Ethicists, economists, physicians and academics gathered for the Institute of Medicine’s National Cancer Policy Forum Workshop this week to discuss the topic.
June 11, 2014
Patients worldwide need access to affordable biosimilars, the World Health Organizations’ World Health Assembly (WHA) says, but not at the expense of safety or science.
June 9, 2014
Medicare beneficiaries and patient advocates breathed a collective sigh of relief last month when the Centers for Medicare and Medicaid Services (CMS) issued its final Part D rule – which targeted program abuse instead of implementing cost-cutting restrictions on medication access.
June 5, 2014
The value of innovative cancer treatments – both in dollars and cents and in human life – takes center stage this month with two complementary efforts to encourage pro-patient policy.
May 29, 2014
What’s in a name? A lot, as the Food and Drug Administration and World Health Organization are discovering.
May 27, 2014
The Food and Drug Administration may require less clinical data to approve biosimilars (imitations of powerful biological medications).
May 23, 2014
By David Charles, MD and Mary Ann Chapman, PhD If requiring biological medications to have unique names would help ensure…
May 20, 2014
Americans covered by a health insurance exchange plan may be paying out for prescription medications in a big way, a new study finds.
